Bernhard Ortel to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Bernhard Ortel has written about Dose-Response Relationship, Drug.
Connection Strength
0.029
-
The new synthetic matrix metalloproteinase inhibitor (Roche 28-2653) reduces tumor growth and prolongs survival in a prostate cancer standard rat model. Oncogene. 2002 Mar 27; 21(13):2089-96.
Score: 0.010
-
Synthetic inhibitor of matrix metalloproteinases (batimastat) reduces prostate cancer growth in an orthotopic rat model. Prostate. 2000 May 01; 43(2):77-82.
Score: 0.009
-
Ultrastructural changes in PAM cells after photodynamic treatment with delta-aminolevulinic acid-induced porphyrins or photosan. J Invest Dermatol. 1999 Mar; 112(3):264-70.
Score: 0.008
-
Ganglioside receptor of rat macrophages. Modulation by enzyme treatment and evidence for its protein nature. Immunology. 1984 Jan; 51(1):177-84.
Score: 0.003